Skip to content

Author

B. Malagutti

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Safety management of anti TROP2 ADCs in patients with breast cancer.

Safety management of TROP2-directed ADCs should be agent-specific, proactive and increasingly individualized and may incorporate pharmacogenomics, longitudinal monitoring, patient-reported outcomes and artificial intelligence to improve toxicity prediction, early detection and adaptive management.

B. Malagutti, Giulia Malvezzi, P. Zagami · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.